We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AbD Serotec and Thermo Fisher Scientific Sign Agreement

By Labmedica staff writers
Posted on 27 Feb 2007
AbD Serotec, a division of MorphoSys (Munich, Germany), and Thermo Fisher Scientific Inc. More...
(Waltham, MA, USA) announced the signing of an agreement covering the use of Thermo Scientific DyLight Dyes in combination with AbD Serotec's diagnostic and research antibodies to prepare a series of fluorescent reagents. The resulting products will be available through the AbD Serotec sales catalogue. Financial details were not disclosed.

DyLight fluorescent dyes, available exclusively as part of Thermo Scientific's protein research product line, are an excellent alternative to other commercially available fluorescent dyes. DyLight dyes are water-soluble and provide high fluorescence intensity in many applications, while maintaining excellent photostability across a broad range of pH values. DyLight dyes are available over a wide range of spectra and match the output wavelengths of common fluorescence instrumentation.

AbD Serotec's product catalog comprises more than 10,000 antibodies and immunology reagents guaranteed to perform to specification. Custom monoclonal antibodies are generated for non-therapeutic applications using the HuCal technology that allows novel antibodies to be generated significantly faster than the current market standard and provides various other advantages over the use of animals for antibody production.

Fluorescent antibodies are particularly suited for detection of specific antigens in tissues or on cells and have become an indispensable tool for scientists worldwide, commented Dr. Achim Knappik senior director of R&D at AbD Serotec. Combining the vast range of research antibodies offered by AbD Serotec with Pierce Biotechnology's fluorescence technology enables AbD Serotec to further expand its wide range of fluorescent reagents, and will thus further enhance our offering in this segment.


Related Links:
MorphoSys
Thermo Fisher Scientific

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.